Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 268 for “"CTLA-4"”.
-
Klinische Erforschung der CTLA-4-Insuffizienz
… in Cytotoxic T-lymphocyte-associated antigen 4 (CTLA4) beeinträchtigen die suppressive Funktion von regulatorischen T-Zellen im menschlichen Immunsystem. Dadurch kommt es zu einer überschießenden Immunantwort und Fehlregulationen, vor allem bei Interaktionen des zellulären Immunsystems. Klinisch …
-
Ctla-4 transcriptional activation: regulation of induced expression
Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is a T cell surface protein that is homologous to CD28 and binds to the B7 family of ligands. Unlike CD28, CTLA-4 interaction transmits a negative signal in T cells, leading to suppression of proliferation. CTLA-4 is constitutively expressed on regulatory T …
-
Understanding control of T cell responses by CTLA-4
Cytotoxic T Lymphocyte Associate Antigen 4 (CTLA-4) is an important negative regulator of T-cell activation. The protein is expressed in activated T-cells and can also be found in regulatory T-cells. The mechanism of action of this protein remains controversial; it has typically been associated …
-
Functional characterization of rat CTLA-4 and CD25+CD4+ regulatory T cells
… rats were examined. At the molecular level, rat CTLA-4, a receptor important for deactivating T cell responses, was examined for the expression pattern and in vitro functions. For this purpose, anti-rat CTLA-4 mAbs were generated. Consistent with the studies in mice and humans, rat CTLA-4 was …
-
Role of the CTLA-4 C-terminus in regulating its intracellular trafficking
CTLA-4 is an important inhibitor of T cell immune responses. The location of CTLA-4 in intracellular vesicles is the most dominating aspect of its biology, yet the significance of this at the functional level remains to be completely understood. I have therefore investigated the role of the CTLA-4 …
-
Μελέτη των πολυμορφισμών του γονιδίου CTLA-4 σε ασθενείς με κακόηθες μελάνωμα
… a large impact upon clinical practice. Specific CTLA-4 polymorphisms have previously shown an association with response to CTLA-4 blockade in patients with metastatic melanoma and the development of autoimmunity. Experimental design: 286 melanoma patients and 288 healthy controls were genotyped …
-
Characterizing and modulating the canine T-cell costimulatory molecules CTLA-4 and CD28
… drugs. T-cell costimulation receptors CD28 and CTLA-4 and their associated antigen presenting cell ligands CD80 and CD86 have a poorly understood relationship. In particular, the mechanisms by which CTLA-4 expressed on the surface of effector and regulatory T-cells leads to suppression of T-cell …
-
Generation and characterization of CD19 CAR T cells with CTLA-4/CD28 fusion receptor
… inhibitory surface markers like PD-L1, TIM-3 and CTLA-4 was observed in CD19 specific CAR T cells after target cell recognition. Next, we detected that overexpression of CTLA-4 on CAR T cells leads to diminished activation and proliferation potential upon antigen stimulation. To circumvent the …
-
Role of the CTLA-4 receptor in regulatory T cell development, homeostasis and function
… that the cytotoxic T lymphocyte antigen-4 (CTLA-4) receptor is constitutively expressed by regulatory T cells and a role for this molecule in Treg suppression has been suggested. This investigation revealed a role for CTLA-4 in maintaining homeostasis of the peripheral regulatory T cell …
-
Novel roles for CD23, CTLA-4 and lipoproteins in human T cell function and differentiation
… demonstrate that stimulation through the TCR and CTLA-4 directs naïve CD4+ T cell differentiation to regulatory T cells in the absence of exogenous cytokines. I evaluate how combined stimuli influence differentiation and function in T cells. Combined stimulation through CTLA-4 and CD28 …
-
DISRUPTION OF CTLA-4 BUT NOT PD-1 ENHANCES AND INVIGORATES CHIMERIC ANTIGEN RECEPTOR T CELLS
… CRISPR-Cas9-mediated disruption of PDCD1 and/or CTLA- 4 in patient T cells could enhance efficacy and restore CART cell function. Indeed, we demonstrate, in both an in vitro model of CART cell dysfunction and xenograft mouse models, that disruption of CTLA-4, but not PDCD1 or PDCD1 and CTLA-4 …
-
Constitutive activation of the Fas/FasL and CD28/CTLA-4 pathways in scurfy mice: implications for peripheral tolerance
… homeostasis, the Fas-FasL pathway and the CD28/CTLA-4/B7 pathway. The Fas pathway is responsible for the activation-induced cell death (AICD) of lymphocytes at the termination of an immune response. It plays a critical role in restoring lymphocyte homeostasis and limiting the potentially …
-
Herstellung und Analyse von rekombinanten anti-CD40 und anti-4-1BB Fusionsproteinen mit CTLA-4-abhängiger agonistischer Aktivität
… zielen einige Therapeutika, wie Ipilimumab (αCTLA-4), darauf ab, diese Inhibitoren zu blockieren. Andere Ansätze stimulieren Rezeptoren und Liganden der Tumornekrosefaktor-Superfamilie (TNFSF), wie 4-1BB und CD40, um die Proliferation und Aktivität immunassoziierter Zellen zu erhöhen. …
-
Induction of T Cell Immunity Overcomes Resistance to Pd-1 and Ctla-4 Blockade and Improves Survival in Pancreatic Cancer
… monoclonal antibodies (mAb) that block PD-1 or CTLA-4 resistance remains common and essentially unexplained. Certain tumors, especially pancreatic carcinoma, are fully refractory to these antibodies. As reported in this thesis, I used a genetically engineered mouse model of pancreatic carcinoma …
Page 1 of 14